Goldman Sachs’s RAPT Therapeutics RAPT Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $178K | Sell |
22,266
-20,508
| -48% | -$164K | ﹤0.01% | 4759 |
|
|
2025
Q1 | $417K | Sell |
42,774
-18,095
| -30% | -$177K | ﹤0.01% | 4352 |
|
|
2024
Q4 | $769K | Buy |
60,869
+11,150
| +22% | +$141K | ﹤0.01% | 4073 |
|
|
2024
Q3 | $799K | Buy |
49,719
+2,995
| +6% | +$48.2K | ﹤0.01% | 3880 |
|
|
2024
Q2 | $1.14M | Buy |
46,724
+23,446
| +101% | +$572K | ﹤0.01% | 3518 |
|
|
2024
Q1 | $1.67M | Sell |
23,278
-1,257
| -5% | -$90.3K | ﹤0.01% | 3306 |
|
|
2023
Q4 | $4.88M | Buy |
24,535
+2,289
| +10% | +$455K | ﹤0.01% | 2611 |
|
|
2023
Q3 | $2.96M | Sell |
22,246
-1,214
| -5% | -$161K | ﹤0.01% | 2838 |
|
|
2023
Q2 | $3.51M | Buy |
23,460
+1,702
| +8% | +$255K | ﹤0.01% | 2821 |
|
|
2023
Q1 | $3.19M | Sell |
21,758
-2,977
| -12% | -$437K | ﹤0.01% | 2881 |
|
|
2022
Q4 | $3.92M | Buy |
24,735
+4,004
| +19% | +$634K | ﹤0.01% | 2811 |
|
|
2022
Q3 | $3.99M | Buy |
20,731
+17,236
| +493% | +$3.32M | ﹤0.01% | 2814 |
|
|
2022
Q2 | $511K | Sell |
3,495
-2,830
| -45% | -$414K | ﹤0.01% | 4365 |
|
|
2022
Q1 | $1.11M | Buy |
6,325
+1,792
| +40% | +$315K | ﹤0.01% | 4027 |
|
|
2021
Q4 | $1.33M | Buy |
4,533
+588
| +15% | +$173K | ﹤0.01% | 3810 |
|
|
2021
Q3 | $980K | Sell |
3,945
-6,160
| -61% | -$1.53M | ﹤0.01% | 3989 |
|
|
2021
Q2 | $2.57M | Buy |
10,105
+8,824
| +689% | +$2.24M | ﹤0.01% | 3307 |
|
|
2021
Q1 | $227K | Sell |
1,281
-783
| -38% | -$139K | ﹤0.01% | 4783 |
|
|
2020
Q4 | $326K | Buy |
+2,064
| New | +$326K | ﹤0.01% | 4042 |
|
|
2020
Q3 | – | Sell |
-11,043
| Closed | -$2.56M | – | 4544 |
|
|
2020
Q2 | $2.56M | Buy |
+11,043
| New | +$2.56M | ﹤0.01% | 2706 |
|